Product Portfolio

Meda has a well-diversified product portfolio, a global presence, and is represented within all areas of pharmaceuticals: Specialty Products, Branded Generics, and OTC.

Meda’s products fall within five therapy areas: respiratory, dermatology, cardiology, pain and inflammation, and CNS, of which respiratory and dermatology are priority areas. In 2012, products in these five therapy areas accounted for 74% of total sales.

 

Sales By Country

Sales by Product Area

Sales of Branded Generics By Country

Print E-mail this page

Meda's financial reports

  •   Interim Report, January–March 2013
  •   Meda AB (publ) – Year-end report, January - December 2012
  • Respiratory
  • Dermatology
  • Cardiology
  • Pain/Inflammation
  • CNS
  • Gastroenterology
  • OTC Products
  • Meda's Pipeline
  • About Meda
  • Product Portfolio
  • Financial information
  • News
  • Corporate Governance
  • CSR
  • Contact us
  • Sitemap »
  • Swedish | 
  • English
Meda Worldwide
  • Sweden
  • Austria
  • Belgium
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Lituania
  • Latvia
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Serbia
  • Slovakia
  • Spain
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • USA

Meda AB
Box 906
SE-170 09 Solna
Sweden

Visitors: Pipers väg 2A
Tel: +46 8-630 19 00
Fax: +46 8-630 19 50
E-mail: info@meda.se

  • Contact »
  • Terms of Use »
  • Privacy Policy »
  • Cookies »
  • Copyright Meda »